Welcome to chemicalbook!
Chinese English Japanese Germany Korea
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List Aripiprazole

Aripiprazole synthesis

6synthesis methods
Aripiprazole, sold under the brand name Abilify among others, is an atypical antipsychotic. It is recommended and primarily used in the treatment of schizophrenia and bipolar disorder. Other uses include as an add-on treatment in major depressive disorder, tic disorders, and irritability associated with autism. Aripiprazole is a quinoline derivate and atypical anti-psychotic agent. Aripiprazole has partial agonistic activity at dopamine D2 receptors and serotonin 5-HT1A receptors, as well as potent antagonistic activity on serotonin 5-HT2A receptors.
Synthetic Routes
  • ROUTE 1
  • 202112075584654569.jpg

    Shi, Hang; Babinski, David J.; Ritter, Tobias. Modular C-H Functionalization Cascade of Aryl Iodides. Journal of the American Chemical Society. Volume 137. Issue 11. Pages 3775-3778. 2015.

  • ROUTE 2
  • 202112070453838870.jpg

    Bonacorsi, Samuel J., Jr.; Waller, Stephen C.; Rinehart, J. Kent. Synthesis of multi-labeled [14C]aripiprazole. Journal of Labelled Compounds & Radiopharmaceuticals. Department of Chemical Synthesis The Bristol-Myers Squibb Pharmaceutical Research Institute. Volume 49. Issue 1. Pages 1-9. 2006.

  • ROUTE 3
  • 202112070992367331.jpg

    Pai, Nandini R.; Dubhashi, Deepnandan S.; Pusalkar, Deeptanshu. Substituted 3,4-dihydro-1H-quinolin-2-one derivatives as potential antidepressant, sedative and antiparkinson agents. International Journal of Pharmaceutical Sciences Review and Research. Department of Organic Chemistry. D.G. Ruparel College. Volume 5. Issue 2. Pages 124-131. 2010.

  • ROUTE 4
  • 202112072661517609.jpg

    Kowalski, Piotr; Jaskowska, Jolanta. An Efficient Synthesis of Aripiprazole, Buspirone and NAN-190 by the Reductive Alkylation of Amines Procedure. Archiv der Pharmazie (Weinheim, Germany). Institute of Organic Chemistry and Technology, Cracow University of Technology. Volume 345. Issue 1. Pages 81-85. Journal. 2012.

  • ROUTE 5
  • 202112070981381976.jpg

    Yang, Li; Shi, Lijun; Xing, Qi; Huang, Kuo-Wei; Xia, Chungu; Li, Fuwei. Enabling CO Insertion into o-Nitrostyrenes beyond Reduction for Selective Access to Indolin-2-one and Dihydroquinolin-2-one Derivatives. ACS Catalysis. State Key Laboratory for Oxo Synthesis and Selective Oxidation, Suzhou Research Institute of LICP, Lanzhou Institute of Chemical Physics (LICP). Chinese Academy of Sciences. Volume 8. Issue 11. Pages 10340-10348. 2018.

  • ROUTE 6
  • 202112073491319835.jpg

    Zhang, Zhaozhen; Zhu, Lihui; Pang, Wen; Zhu, Yidong; Hou, Zijie. Synthesis of aripiprazole. Zhongguo Yiyao Gongye Zazhi. Qilu Pharmaceutical Co., Ltd. Volume 40. Issue 1. Pages 6-8. 2009.

  • ROUTE 7
  • 202112073076284444.jpg

    Liu, Xiu-jie; Wang, Ti-ti; Zhong, Yong-liang; Wang, Xiao. Synthesis of antipsychotic aripiprazole. Shenyang Yaoke Daxue Xuebao. The College of Chemistry and Chemical Engineering, Tianjin University of Technology. Volume 30. Issue 4. Pages 253-255. 2013.

  • ROUTE 8
  • 202112076678056347.jpg

    Kollapudi, Chandra Babu; Gutta, Madhusudhan; Reguri, Buchi Reddy. Green methodologies in organic synthesis: microwave-assisted study on carbostyril derivatives under phase transfer catalysis. Heterocyclic Letters. Centre for Pharmaceutical Sciences, JNT University. Volume 5. Issue 2. Pages 213-221. 2015.

  • ROUTE 9
  • 202112074240908414.jpg

    Czarnik, Anthony W. Deuterium-enriched aripiprazole for treatment of schizophrenia. Assignee Protia, LLC. 2008.

  • ROUTE 10
  • 202112078848407232.jpg

    Du, Xiaochun; Qin, Xinrong; Cai, Fubo; Xu, Guanbing; Li, Wen. A process for preparing aripiprazole and its intermediates. Assignee Chengdu Kanghong Pharmaceutical Group Co., Ltd.2009.

202112075584654569.jpg

Shi, Hang; Babinski, David J.; Ritter, Tobias. Modular C-H Functionalization Cascade of Aryl Iodides. Journal of the American Chemical Society. Volume 137. Issue 11. Pages 3775-3778. 2015.

-

Yield:129722-12-9 99.3%

Reaction Conditions:

at 100 - 120; for 21 h;Industrial scale;

Steps:

1 Example 1

Example 1
The aripiprazole hydrate A (powder) (44.29 kg) obtained in the Reference Example 4 was dried at 100° C. for 18 hours by using a hot air dryer and further heated at 120° C. for 3 hours, to obtain 42.46 kg (yield; 99.3%) of Anhydrous Aripiprazole Crystals B. These Anhydrous Aripiprazole Crystals B had a melting point (mp) of 139.7° C.
The Anhydrous Aripiprazole Crystals B obtained above had an 1H-NMR spectrum (DMSO-d6, TMS) which was substantially identical to the 1H-NMR spectrum shown in .
Specifically, they had characteristic peaks at 1.55-1.63 ppm (m, 2H), 1.68-1.78 ppm (m, 2H), 2.35-2.46 ppm (m, 4H), 2.48-2.56 ppm (m, 4H+DMSO), 2.78 ppm (t, J=7.4 Hz, 2H), 2.97 ppm (brt, J=4.6 Hz, 4H), 3.92 ppm (t, J=6.3 Hz, 2H), 6.43 ppm (d, J=2.4 Hz, 1H), 6.49 ppm (dd, J=8.4 Hz, J=2.4 Hz, 1H), 7.04 ppm (d, J=8.1 Hz, 1H), 7.11-7.17 ppm (m, 1H), 7.28-7.32 ppm (m, 2H) and 10.00 ppm (s, 1H).
The Anhydrous Aripiprazole Crystals B obtained above had a powder x-ray diffraction spectrum which was substantially the identical to the powder x-ray diffraction spectrum shown in .
Specifically, they had characteristic peaks at 2θ=11.0°, 16.6°, 19.3°, 20.3° and 22.1°.
The Anhydrous Aripiprazole Crystals B obtained above had remarkable infrared absorption bands at 2945, 2812, 1678, 1627, 1448, 1377, 1173, 960 and 779 cm-1 on the IR (KBr) spectrum.

References:

US9387182,2016,B2 Location in patent:Page/Page column 17

2(1H)-Quinolinone, 3,4-dihydro-7-(2-propen-1-yloxy)-

177419-01-1
1 suppliers
inquiry

201230-82-2 Synthesis
carbon monoxide

201230-82-2
1 suppliers
inquiry

41202-77-1 Synthesis
1-(2,3-Dichlorophenyl)-piperazine

41202-77-1
254 suppliers
inquiry

Aripiprazole Related Search: